During this webinar, attendees will learn about Thermo Fisher Scientific’s new 5KL bioreactor and how it benefits clients who outsource late-phase biologics drug substance manufacturing.

An introduction of the 5KL bioreactor will be provided, as well as application data around performance and scalability, process economy comparison with traditional stainless steel bioreactors, and decision criteria that could be helpful in choosing between different cell culture strategies. Save Your Spot Today!